<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Wisdomtree Interest Rate Hedged U.s. Aggregate Bond Fund — News on 6ix</title>
    <link>https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund</link>
    <description>Latest news and press releases for Wisdomtree Interest Rate Hedged U.s. Aggregate Bond Fund on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 02 Apr 2026 04:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund" rel="self" type="application/rss+xml" />
    <item>
      <title>PureTech Announces Publication of Phase 2b ELEVATE IPF Trial Results in The American Journal of Respiratory and Critical Care Medicine</title>
      <link>https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/puretech-announces-publication-of-phase-2b-elevate-ipf-trial-results-in-the-american-journal-of-respiratory-and-critical-care-medicine-41</link>
      <guid isPermaLink="true">https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/puretech-announces-publication-of-phase-2b-elevate-ipf-trial-results-in-the-american-journal-of-respiratory-and-critical-care-medicine-41</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>Deupirfenidone 825 mg TID monotherapy significantly slowed lung function decline versus placebo at 26 weeks in people with idiopathic pulmonary fibrosis</description>
    </item>
    <item>
      <title>Dalrada Technology Group, Inc. Announces Agreement Supporting Ultra-High Temperature Industrial Heat Pump Development</title>
      <link>https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/dalrada-technology-group-inc-announces-agreement-supporting-ultra-high-temperature-industrial-heat-pump-development-15</link>
      <guid isPermaLink="true">https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/dalrada-technology-group-inc-announces-agreement-supporting-ultra-high-temperature-industrial-heat-pump-development-15</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>ESCONDIDO, CA / ACCESS Newswire / April 2, 2026 / Dalrada Technology Group, Inc. (the &quot;Company&quot; or &quot;Dalrada&quot;) (OTCID:DHTI), a leader in advanced climate</description>
    </item>
    <item>
      <title>Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market</title>
      <link>https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/intelligent-bio-solutions-completes-clinical-cut-off-study-advances-fda-510k-clinical-program-targeting-multi-billion-dollar-us-drug-screening-market-5</link>
      <guid isPermaLink="true">https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/intelligent-bio-solutions-completes-clinical-cut-off-study-advances-fda-510k-clinical-program-targeting-multi-billion-dollar-us-drug-screening-market-5</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>Study results finalized on schedule support FDA clearance and planned U.S. commercial launch Company advances second phase of clinical program for 510(k)</description>
    </item>
    <item>
      <title>Zoetis to Host Webcast and Conference Call on First Quarter 2026 Financial Results</title>
      <link>https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/zoetis-to-host-webcast-and-conference-call-on-first-quarter-2026-financial-results-33</link>
      <guid isPermaLink="true">https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/zoetis-to-host-webcast-and-conference-call-on-first-quarter-2026-financial-results-33</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>PARSIPPANY, N.J.--(BUSINESS WIRE)-- Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, May 7, 2026. Chief</description>
    </item>
    <item>
      <title>Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System</title>
      <link>https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/dermata-receives-notice-of-acceptance-of-australian-patent-application-for-topical-application-of-dermal-fillers-with-its-bioneedle-delivery-system-26</link>
      <guid isPermaLink="true">https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/dermata-receives-notice-of-acceptance-of-australian-patent-application-for-topical-application-of-dermal-fillers-with-its-bioneedle-delivery-system-26</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>- This would be Dermata&apos;s first patent, if issued, covering the use of its Bioneedle Delivery System (&quot;BDS&quot;) with dermal fillers -- The Company also has</description>
    </item>
    <item>
      <title>CSW Industrials Increases Quarterly Dividend by 11% to $0.30 Per Share and Repurchases $35M in Shares During the Fiscal Fourth Quarter of 2026</title>
      <link>https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/csw-industrials-increases-quarterly-dividend-by-11percent-to-dollar030-per-share-and-repurchases-dollar35m-in-shares-during-the-fiscal-fourth-quarter-of-2026-9</link>
      <guid isPermaLink="true">https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/csw-industrials-increases-quarterly-dividend-by-11percent-to-dollar030-per-share-and-repurchases-dollar35m-in-shares-during-the-fiscal-fourth-quarter-of-2026-9</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>DALLAS, April 02, 2026 (GLOBE NEWSWIRE) -- CSW Industrials, Inc. (NYSE: CSW) announced today that its Board of Directors has declared a regular quarterly cash</description>
    </item>
    <item>
      <title>IFF Launches PureStrong™, a Probiotic Made Specifically for Dogs</title>
      <link>https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/iff-launches-purestrongtm-a-probiotic-made-specifically-for-dogs-35</link>
      <guid isPermaLink="true">https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/iff-launches-purestrongtm-a-probiotic-made-specifically-for-dogs-35</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>NEW YORK--(BUSINESS WIRE)-- IFF (NYSE: IFF)—a global leader in flavors, fragrances, food ingredients and health &amp; biosciences—is introducing PureStrong™, a</description>
    </item>
    <item>
      <title>Carpenter Technology Announces Conference Call and Webcast</title>
      <link>https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/carpenter-technology-announces-conference-call-and-webcast-2</link>
      <guid isPermaLink="true">https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/carpenter-technology-announces-conference-call-and-webcast-2</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>PHILADELPHIA, April 02, 2026 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) plans to host a conference call and webcast on Wednesday, April</description>
    </item>
    <item>
      <title>Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution</title>
      <link>https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/worksport-announces-cortm-portable-energy-system-is-now-fully-certified-including-key-ul-and-csa-approvals-for-north-american-retail-and-commercial-distribution-21</link>
      <guid isPermaLink="true">https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/worksport-announces-cortm-portable-energy-system-is-now-fully-certified-including-key-ul-and-csa-approvals-for-north-american-retail-and-commercial-distribution-21</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>Final safety and compliance approvals complete; certification package supports broader sales across retail, fleet, distributor, and commercial channels WEST</description>
    </item>
    <item>
      <title>ZenaTech Initiates New Operations in Ukraine to Accelerate Production of Counter-UAS Interceptor Systems</title>
      <link>https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/zenatech-initiates-new-operations-in-ukraine-to-accelerate-production-of-counter-uas-interceptor-systems-8</link>
      <guid isPermaLink="true">https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/zenatech-initiates-new-operations-in-ukraine-to-accelerate-production-of-counter-uas-interceptor-systems-8</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>Ukraine operations will be structured for full regulatory compliance to support U.S. defense and Gulf nation adoption VANCOUVER, British Columbia, April 02,</description>
    </item>
    <item>
      <title>BrightSpire Capital, Inc. Announces First Quarter 2026 Earnings Release and Conference Call Dates</title>
      <link>https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/brightspire-capital-inc-announces-first-quarter-2026-earnings-release-and-conference-call-dates-35</link>
      <guid isPermaLink="true">https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/brightspire-capital-inc-announces-first-quarter-2026-earnings-release-and-conference-call-dates-35</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>NEW YORK--(BUSINESS WIRE)-- BrightSpire Capital, Inc. (NYSE: BRSP) (“BrightSpire Capital” or the “Company”) today announced it will release first quarter</description>
    </item>
    <item>
      <title>Pineapple Financial Deepens Strategic Relationship with Canary Capital</title>
      <link>https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/pineapple-financial-deepens-strategic-relationship-with-canary-capital-24</link>
      <guid isPermaLink="true">https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/pineapple-financial-deepens-strategic-relationship-with-canary-capital-24</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>Appoints Digital Asset Treasury Advisor, Bringing Institutional Portfolio Construction and Capital Strategy Expertise Toronto, Ontario--(Newsfile Corp. -</description>
    </item>
    <item>
      <title>Ultragenyx Announces U.S. FDA Acceptance of BLA Resubmission for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)</title>
      <link>https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/ultragenyx-announces-us-fda-acceptance-of-bla-resubmission-for-ux111-aav-gene-therapy-to-treat-sanfilippo-syndrome-type-a-mps-iiia-7</link>
      <guid isPermaLink="true">https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/ultragenyx-announces-us-fda-acceptance-of-bla-resubmission-for-ux111-aav-gene-therapy-to-treat-sanfilippo-syndrome-type-a-mps-iiia-7</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>If approved, UX111 will be the first approved therapy for the treatment of Sanfilippo syndrome Type A, a rare disease affecting young children that leads to</description>
    </item>
    <item>
      <title>RXO Schedules First-Quarter 2026 Earnings and Investor Conference Call for May 7, 2026</title>
      <link>https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/rxo-schedules-first-quarter-2026-earnings-and-investor-conference-call-for-may-7-2026-34</link>
      <guid isPermaLink="true">https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/rxo-schedules-first-quarter-2026-earnings-and-investor-conference-call-for-may-7-2026-34</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>CHARLOTTE, N.C.--(BUSINESS WIRE)-- RXO (NYSE: RXO) will issue its first-quarter financial results before the opening of the New York Stock Exchange on</description>
    </item>
    <item>
      <title>Quantum BioPharma Wins Significant Court Challenge in USD $700,000,000 Claim as Defendants Joint Motion to Dismiss Lawsuit Alleging Market Manipulation by CIBC World Markets and RBC Dominion Securities is Denied</title>
      <link>https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/quantum-biopharma-wins-significant-court-challenge-in-usd-dollar700000000-claim-as-defendants-joint-motion-to-dismiss-lawsuit-alleging-market-manipulation-by-cibc-world-markets-and-rbc-dominion-securities-is-denied-1</link>
      <guid isPermaLink="true">https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/quantum-biopharma-wins-significant-court-challenge-in-usd-dollar700000000-claim-as-defendants-joint-motion-to-dismiss-lawsuit-alleging-market-manipulation-by-cibc-world-markets-and-rbc-dominion-securities-is-denied-1</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>TORONTO, April 02, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a</description>
    </item>
    <item>
      <title>Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies</title>
      <link>https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/biodexa-announces-partnership-with-syngene-to-manufacture-mtx240-gmp-clinical-trial-supplies-7</link>
      <guid isPermaLink="true">https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/biodexa-announces-partnership-with-syngene-to-manufacture-mtx240-gmp-clinical-trial-supplies-7</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>April 2, 2026 Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies Biodexa Pharmaceuticals PLC (Nasdaq: BDRX)</description>
    </item>
    <item>
      <title>Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update</title>
      <link>https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/onconetix-highlights-realbotix-ai-humanoid-robot-delivery-update-1</link>
      <guid isPermaLink="true">https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/onconetix-highlights-realbotix-ai-humanoid-robot-delivery-update-1</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>Realbotix Announces Expected Delivery of 19 Robots in March, April, and May 2026 as it Scales Production Capacity; Onconetix recently Entered into a</description>
    </item>
    <item>
      <title>Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York</title>
      <link>https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/abeona-therapeuticsr-announces-new-qualified-treatment-center-for-zevaskynr-in-new-york-5</link>
      <guid isPermaLink="true">https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/abeona-therapeuticsr-announces-new-qualified-treatment-center-for-zevaskynr-in-new-york-5</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>CLEVELAND, April 02, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced activation of NewYork-Presbyterian/Columbia University</description>
    </item>
    <item>
      <title>InterDigital signs license agreement with Buffalo Americas; adds new DTV agreements</title>
      <link>https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/interdigital-signs-license-agreement-with-buffalo-americas-adds-new-dtv-agreements-4</link>
      <guid isPermaLink="true">https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/interdigital-signs-license-agreement-with-buffalo-americas-adds-new-dtv-agreements-4</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>WILMINGTON, Del., April 02, 2026 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a wireless, video, and AI technology research and development company,</description>
    </item>
    <item>
      <title>Manhattan Named a Leader in 2026 Gartner® Magic Quadrant™ for Transportation Management Systems</title>
      <link>https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/manhattan-named-a-leader-in-2026-gartnerr-magic-quadranttm-for-transportation-management-systems-21</link>
      <guid isPermaLink="true">https://6ix.com/company/wisdomtree-interest-rate-hedged-us-aggregate-bond-fund/news/manhattan-named-a-leader-in-2026-gartnerr-magic-quadranttm-for-transportation-management-systems-21</guid>
      <pubDate>Thu, 02 Apr 2026 04:00:00 GMT</pubDate>
      <description>ATLANTA--(BUSINESS WIRE)-- Manhattan Associates Inc. (NASDAQ: MANH), a global leader in supply chain commerce solutions with unmatched AI capabilities,</description>
    </item>
  </channel>
</rss>